We are currently facing an issue in receiving the NSE feed. Hence the stock prices are not updated. We are working on fixing this at the earliest. We regret the inconvenience caused.

Sensex Ends the Week on Dull Note, Infosys Falls 2.3%

Fri, 14 Oct Closing

   09:30 am   

   Previous Close   

   Pre-Open   

   0   

   11:30 am   

   01:30 pm   

Indian share markets continued to trade range-bound in the afternoon session thus ending on a flat note. At the closing bell, the BSE Sensex stood higher by 30 points, while the NSE Nifty finished higher by 10 points. The S&P BSE Mid Cap & the S&P BSE Small Cap finished higher by 0.8% each. Barring IT and metal sectors, all the sectoral indices finished in the green. Gains were largely seen in oil & gas & capital goods stocks.

Infosys shares tumbled as much as 5.3% to their lowest since July 20, 2015 after the company cut its fiscal-year revenue growth target for a second time in three months on an uncertain business outlook. Click here to access the Q2 results for Infosys Ltd.

Asian markets finished higher with shares in Hong Kong leading the region. The Hang Seng is up 0.88%, while Japan's Nikkei 225 is up 0.49% and China's Shanghai Composite is up 0.08%. European markets are also broadly trading higher today with shares in France leading the region. The CAC 40 is up 1.76%, while Germany's DAX is up 1.59% and London's FTSE 100 is up 0.83%.

The rupee was trading at 66.85 against the US$ in the afternoon session.

As per an article in Livemint, Cipla received clearance from the US Food and Drug Administration (USFDA) pertaining to its plant in Indore.

The company had received a warning letter pertaining to this plant in October 2015. This clearance will open up opportunities to get approvals for products filled from this facility for the US generics market.

However, it is imperative to note that Cipla's main market is India and it gets 40% of its revenues from here. US just accounts for around 18% of the company's revenues. Hence, the clearance of this facility may not prove to be a great revenue booster for the company in the near term.

Having said that, lately the company has been aiming for a much bigger presence in the US generics market. This is evident in this quarter's result, wherein sales in the US territory increased by a robust 30% as compared to the same quarter in the previous year.

Hence, the clearance of this facility could possibly matter a lot in the long run wherein the company will increasingly focus its concentration in the US. The share price of Cipla ended the day trading higher by 0.8%.

In another news update, the government is seeking a parliamentary approval to spend about US$ 7.5 billion more on roads, railways and other public programmes.

The decision comes at a time when private investments have continued to remain weak. This is on account of their highly leveraged balance sheets coupled with excess capacities and banks' reluctance to lend to the corporate sector on the back of the ongoing bad loan scenario.

It is imperative to note that the government has already exhausted around 73.7% of the annual fiscal deficit budget targets in the first four months of this fiscal year.

A point that needs to be mentioned here is that the expenditure of the government is front loaded, whereas a major chunk of its revenues start to come in only in the second half of the year. However, even with this disclaimer, the expenditure of government looks far more than its receipts in FY17.

Going by the current scenario, the government's fiscal deficit target seems to be under stress. And this begs the question: What shall the government do to keep its bargain on the fiscal deficit front?

Vivek Kaul, editor of Vivek Kaul's Diary, has answered this question in one of his recent articles. He has also just launched the Vivek Kaul Letter which outlines the Indian economy and its many challenges.

Apurva's First-Ever Training Session

For those into technical analysis, we have some good news for you. Apurva Seth, Managing Editor of Swing Trader, our popular charting service, will be conducting his first-ever training session today at 5pm.

You can attend the session from the comfort of your home or office and access it on your desktop or mobile. And before you ask...it's completely free. Yes, you read that correctly. Apurva wants the maximum number of people to benefit from the session. So we are inviting everyone who is interested in trading to attend. Please book your seat for this training session immediately.

The big draw of the session is that Apurva will be revealing what he calls his 'Secret Profit Signal'. What's that? Here's Apurva in his own words:

• Well, the Secret Profit Signal is a method I designed after years of tracking the markets. This signal has helped me identify numerous money-making opportunities in the markets. It has stood the test of time and delivered solid returns across market conditions.
  
  During 2016, this signal has helped me identify numerous trading opportunities and delivered returns such as 11.15% in ten days, 18.24% in nineteen days, 15.79% in six days, and so on.
  
   With this method, I have guided numerous mutual funds, insurance companies, and foreign institutional investors (FIIs) to solid profits. And since joining Daily Profit Hunter two years ago, I have been using the same method and guiding our subscribers to solid profits.
  
   And now I want all our readers to benefit from it. That's why I am conducting this session and revealing my Secret Profit Signal.

And that's not all. Apurva has a surprise gift for everyone who attends - his 66-page PDF guide, Profit Triggers.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers